Vitamin D and the skin

Journal of Dermatology

Volumn 30, Issue 6, 2003, Pages 429-437

  Kira, Masahiro ^a   Kobayashi, Teruaki ^a   Yoshikawa, Kunihiko ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Psoriasis; Vitamin D; Vitamin D3 analogue

Indexed keywords

22 OXACALCITRIOL; CALCIPOTRIOL; TACALCITOL; VITAMIN D;

BONE METABOLISM; CALCIUM METABOLISM; CELL DIFFERENTIATION; CELL GROWTH; CREAM; DRUG FORMULATION; DRUG INDICATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG USE; HUMAN; ICHTHYOSIS; KERATINOCYTE; KERATOSIS PALMARIS; LOTION; OINTMENT; PSORIASIS; PUSTULOSIS PALMOPLANTARIS; REVIEW; SKIN;

EID: 0038270067     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2003.tb00412.x     Document Type: Review

References (51)

1. Kobayashi T, Okano T, Shida S, et al: Variation of 25-hydroxyvitamin D3 and 25-hydroxyvitamin D2 levels in human plasma obtained from 758 Japanese healthy subjects, J Nutr Sci Vitaminol, 29: 271-281, 1983.
2. Malvy DJ, Guinot C, Prexiosi P, et al: Relationship between vitamin D status and skin phototype in general adult population, Photochem Photobiol, 71: 466-469, 2000.
3. Schuessler M, Astecker N, Herzig G, Vorisek G, Schuster I: Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D (3): CYP27 in epidermis completes the set of essential vitamin D (3)-hydroxylases, Steroids, 66: 399-408, 2001.
4. Baker AR, McDonnell DP, Hughes M, et al: Cloning and expression of full-length cDNA encoding human vitamin D receptor, Proc Natl Acad Sci USA, 85: 3294-3298, 1988.
5. Park BS, Park JS, Lee DY, Youn JI, Kim IG: Vitamin D receptor polymorphism is associated with psoriasis, J Invest Dermatol, 112: 113-116, 1999.
6. Solvsten H, Fogh K, Svendsen M, et al: Normal levels of the vitamin D receptor and its message in psoriatic skin, J Investig Dermatol Symp Proc, 1: 28-32, 1996.
7. Abe E, Miyaura C, Sakagami H, et al: Differentiation of mouse myeloid leukemia cells induced by 1 alpha, 25-dihydroxyvitamin D3, Proc Natl Acad Sci USA, 78: 4990-4994, 1981.
8. Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T: Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha, 25-dihydroxyvitamin D3, Endocrinology, 113: 1950-1957, 1983.
9. Morimoto S, Kumahara Y: A patient with psoriasis cured by 1 alpha-hydroxyvitamin D3, Med J Osaka Univ, 35: 51-54, 1985.
10. Morimoto S, Yoshikawa K, Kozuka T, et al: An open study of vitamin D3 treatment in psoriasis vulgaris, Br J Dermatol, 115: 421-429, 1986.
11. van de Kerkhof PC: Therapeutic strategies: Rotational therapy and combinations, Clin Exp Dermatol, 26: 356-361, 2001.
12. De Rie MA, Di Nuzzo S, Brands S, Hansen AB, Bos JD: Calcipotriol ointment and cream or their vehicles applied immediately before irradiation inhibit ultraviolet B-induced erythema, Br J Dermatol, 142: 1160-1165, 2000.
13. Courtois SJ, Segaert S, Degreef H, Bouillon R, Garmyn M: Ultraviolet B suppresses vitamin D receptor gene expression in keratinocytes, Biochem Biophys Res Commun, 246: 64-69, 1998.
14. Ring J, Kowalzick L, Christophers E, et al: Calcitriol 3 microg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: Results of a comparative study, Br J Dermatol, 144: 495-499, 2001.
15. Gibson DF, Bikle DD, Harris J: All-trans retinoic acid blocks the antiproliferative prodifferentiating actions of 1,25-dihydroxyvitamin D3 in normal human keratinocytes, J Cell Physiol, 174: 1-8, 1998.
16. Segaert S, Garmyn M, Degreef H, Bouillon R: Retinoic acid modulates the anti-proliferative effect of 1,25-dihydroxyvitamin D3 in cultured human epidermal keratinocytes, J Invest Dermatol, 109: 46-54, 1997.
17. Frosch PJ, Rustemeyer T: Contact allergy to calcipotriol does exist. Report of an unequivocal case and review of the literature, Contact Dermatitis, 40: 66-71, 1999.
18. Krayenbuhl BH, Elsner P: Allergic and irritant contact dermatitis to calciportriol, Am J Contact Dermat, 10: 78-80, 1999.
19. Hamamoto Y, Nagai K, Yasui H, Muto M: Hyperreactivity of pseudoxanthoma elasticum-affected dermis to vitamin D3, J Am Acad Dermatol, 42: 685-687, 2000.
20. Kobayashi T, Hashimoto K, Yoshikawa K: Growth inhibition of human keratinocytes by MC903 (calcipotriol) is linked to dephosphorylation of retinoblastoma gene product, Journal of the European Academy of Dermatology and Venereology, 5: 132-138, 1995.
21. Mommers JM, ter Meulen AC, van Erp PE, van de Kerkhof PC: Influence of tacalcitol on cell cycle kinetics of human keratinocytes following standardized injury, Skin Pharmacol Appl Skin Physiol, 12: 174-181, 1999.
22. Matsumoto K, Hashimoto K, Nishida Y, Hashiro M, Yoshikawa K: Growth-inbibitory effects of 1,25-dihydroxyvitamin D3 on normal human keratinocytes cultured in serum-free medium, Biochem Biophys Res Commun, 166: 916-923, 1990.
23. Bikle DD, Ng D, Oda Y, Hanley K, Feingold K, Xie Z: The vitamin D response element of the involucrin gene mediates its regulation by 1,25-dihydroxyvitamin D3, J Invest Dermatol, 119: 1109-1113, 2002.
24. Matsumoto K, Hashimoto K, Kiyoki M, Yamamoto M, Yoshikawa K: Effect of 1,24 R-dihydroxyvitamin D3 on the growth of human keratinocytes, J Dermatol, 17: 97-103, 1990.
25. Griner RD, Qin F,Jung E, et al: 1,25-dihydroxvitamin D3 induces phospholipase D-1 expression in primary mouse epidermal keratinocytes, J Biol Chem, 274: 4663-4670, 1999.
26. Matsumoto K, Azuma Y, Kiyoki M, Okumura H, Hashimoto K, Yoshikawa K: Involvement of endogenously produced 1,25-dihydroxyvitamin D-3 in the growth and differentiation of human keratinocytes, Biochim Biophys Acta, 1092: 311-318, 1991.
27. Barna M, Bos JD, Kapsenberg ML, Snijdewint FG: Effect of calcitriol on the production of T-cell-derived cytokines in psoriasis, Br J Dermatol, 136: 536-541, 1997.
28. Kang S, Yi S, Griffiths CE, Fancher L, Hamilton TA, Choi JH: Calcipotriene-induced improvement in psoriasis is associated with reduced interleukin-8 and increased interleukin-10 levels within lesions, Br J Dermatol, 138: 77-83, 1998.
29. Michel G, Gailis A, Jarzebska-Deussen B, Muschen A, Mirmohammadsadegh A, Ruzicka T: 1,25-(OH) 2-vitamin D3 and calcipotriol induce IL-10 receptor gene expression in human epidermal cells, Inflamm Res, 46: 32-34, 1997.
30. Tomita Y, Torinuki W, Tagami H: Stimulation of human melanocytes by vitamin D3 possibly mediates skin pigmentation after sun exposure, J Invest Dermatol, 90: 882-884, 1988.
31. Cornish DA, Maluleke V, Mhlanga T: An investigation into a possible relationship between vitamin D, parathyroid hormone, calcium and magnesium in a normally pigmented and an albino rural black population in the Northern Province of South Africa, Biofactors, 11: 35-38, 2000.
32. Parsad D, Saini R, Nagpal R: Calcipotriol in vitiligo: A preliminary study, Pediatr Dermatol, 16: 317-320, 1999.
33. Chida K, Hashiba H, Fukushima M, Suda T, Kuroki T: Inhibition of tumor promotion in mouse skin by 1 alpha, 25-dihydroxyvitamin D3, Cancer Res, 45: 5426-5430, 1985.
34. MacLaughlin J, Holick MF: Aging decreases the capacity of human skin to produce vitamin D3, J Clin Invest, 76: 1536-1538, 1985.
35. Fujimura T, Moriwaki S, Takema Y, Imokawa G: Epidermal change can alter mechanical properties of hairless mouse skin topically treated with 1-alpha, 25-dihydroxyvitamin D (3), J Dermatol Sci, 24: 105-111, 2000.
36. Sakai Y, Kishimoto J, Demay MB: Metabolic and cellular analysis of alopecia in vitamin D receptor knockout mice, J Clin Invest, 107: 961-966, 2001.
37. Kong J, Li XJ, Gavin D, Jiang Y, Li YC: Targeted expression of human vitamin D receptor in the skin promotes the initiation of the postnatal hair follicle cycle and rescues the alopecia in vitamin D receptor null mice, J Invest Dermatol, 118: 631-638, 2002.
38. Xie Z, Komuves L, Yu QC, et al: Lack of the vitamin D receptor is associated with reduced epidermal differentiation and hair follicle growth, J Invest Dermatol, 118: 11-16, 2002.
39. Miller J, Djabali K, Chen T, et al: Atrichia caused by mutations in the vitamin D receptor gene is a phenocopy of generalized atrichia caused by mutations in the hairless gene, J Invest Dermatol, 117: 612-617, 2001.
40. Vegesna V, O'Kelly J, Uskokovic M, et al: Vitamin D3 analogs stimulate hair growth in nude mice, Endocrinology, 143: 4389-4396, 2002.
41. Kensler TW, Dolan PM, Gange SJ, Lee JK, Wang Q, Posner GH: Conceptually new deltanoids (vitamin D analogs) inhibit multistage skin tumorigenesis, Carcinogenesis, 21: 1341-1345, 2000.
42. Chen TC, Holick MF: Hexafluoro-1,25-dihydroxvitamin D3 has markedly increased potency in inhibiting proliferation of cultured human keratinocytes compared with 1,25-dihydroxyvitamin D3, Br J Dermatol, 143: 72-78, 2000.
43. Durakovic C, Malabanan A, Holick MF: Rationale for use and clinical responsiveness of hexafluoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: A pilot study, Br J Dermatol, 144: 500-506, 2001.
44. Werz O, Wiesinger H, Steinmeyer A, Steinhilber D: New vitamin D receptor agonists with decreased metabolic stability, Biochem Pharmacol, 59: 1597-1601, 2000.
45. Flanagan JN, Whitlatch LW, Chen TC, et al: Enhancing 1 alpha-hydroxylase activity with the 25-hydroxyvitamin D-1 alpha-hydroxylase gene in cultured human keratinocytes and mouse skin, J Invest Dermatol, 116: 910-914, 2001.
46. Cunningham BB, Landells ID, Langman C, Sailer DE, Paller AS: Topical calcipotriene for morphea/linear scleroderma, J Am Acad Dermatol, 39: 211-215, 1998.
47. Kreuter A, Gambichler T, Avermaete A, et al: Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea, Pediatr Dermatol, 18: 241-245, 2001.
48. Masood R, Nagpal S, Zheng T, et al: Kaposi sarcoma is a therapeutic target for vitamin D (3) receptor agonist, Blood, 96: 3188-3194, 2000.
49. Bohm M, Luger TA, Bonsmann G: Disseminated superficial actinic porokeratosis: Treatment with topical tacalcitol, J Am Acad Dermatol, 40: 479-480, 1999.
50. Chang SE, Jung EC, Hong SM, et al: Keratosis lichenoides chronica: Marked response to calcipotriol ointment, J Dermatol, 27: 123-126, 2000.
51. Gniadecki R: Calcipotriol for erythema annulare centrifugum, Br J Dermatol, 146: 317-319, 2002.